Drug · DIN 02229639
ZOFRAN
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since March 14, 2017; first marketed November 13, 1996.
- Drug Identification Number (DIN)
- 02229639
- Company (DIN owner)
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Oral
- Therapeutic class (ATC)
- Ondansetron A04AA01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ONDANSETRON (ONDANSETRON HYDROCHLORIDE DIHYDRATE) | 4 MG | 5 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 30, 2015: NOC 17148New Drug Submission (NDS) · Transfer of Drug Identification Numbers
- August 7, 2001: NOC 2491New Drug Submission (NDS) · Change in manufacturer name
- September 26, 1996: NOC 4597Supplement to a New Drug Submission (SNDS) · New dosage form
Other DINs named ZOFRAN
- DIN 02213567 · Cancelled Post Market
- DIN 02213575 · Cancelled Post Market
- DIN 02213745 · Cancelled Post Market